Global Narcolepsy Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Narcolepsy Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.
The narcolepsy drug is the drug to treat narcolepsy.
Narcolepsy Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Narcolepsy Drug market is projected to reach US$ 5628.2 million in 2034, increasing from US$ 2775.5 million in 2022, with the CAGR of 10.5% during the period of 2024 to 2034. Demand from Daytime Extreme Sleepiness and Cataplexia are the major drivers for the industry.
Market competition is concentrated. Jazz Pharmaceuticals, Teva Pharmaceutical, Novartis and Mylan. are the leaders of the industry, with about 91% market shares.
Europe is the largest consumption place, with a consumption market share nearly 58%. Following Europe, USA is the second largest consumption place with the consumption market share of 29%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Narcolepsy Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Jazz Pharmaceuticals
Teva Pharmaceutical
Novartis
Mylan
Segment by Type
Antioxidants Type
Stimulants Type
Others
Daytime Extreme Sleepiness
Cataplexia
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Narcolepsy Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Narcolepsy Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Narcolepsy Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Narcolepsy Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Narcolepsy Drug introduction, etc. Narcolepsy Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Narcolepsy Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
The narcolepsy drug is the drug to treat narcolepsy.
Narcolepsy Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Narcolepsy Drug market is projected to reach US$ 5628.2 million in 2034, increasing from US$ 2775.5 million in 2022, with the CAGR of 10.5% during the period of 2024 to 2034. Demand from Daytime Extreme Sleepiness and Cataplexia are the major drivers for the industry.
Market competition is concentrated. Jazz Pharmaceuticals, Teva Pharmaceutical, Novartis and Mylan. are the leaders of the industry, with about 91% market shares.
Europe is the largest consumption place, with a consumption market share nearly 58%. Following Europe, USA is the second largest consumption place with the consumption market share of 29%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Narcolepsy Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Jazz Pharmaceuticals
Teva Pharmaceutical
Novartis
Mylan
Segment by Type
Antioxidants Type
Stimulants Type
Others
Segment by Application
Daytime Extreme Sleepiness
Cataplexia
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Narcolepsy Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Narcolepsy Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Narcolepsy Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Narcolepsy Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Narcolepsy Drug introduction, etc. Narcolepsy Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Narcolepsy Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices